EPISODE · Apr 11, 2025 · 0 MIN
FDA Approves Axsome's New Migraine Drug Symbravo®
from Migraine Minute News Update
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O'Brien has the details and when it becomes available in this Migraine Minute News update. Learn More: https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam
Embed this episode
NOW PLAYING
FDA Approves Axsome's New Migraine Drug Symbravo®
0:00
0:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Migraine Minute News Update?
This episode is 0 minutes long.
When was this Migraine Minute News Update episode published?
This episode was published on April 11, 2025.
Can I download this Migraine Minute News Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!